DUBLIN, Feb. 1, 2022 \/PRNewswire\/ -- The \"Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027\" report has been added to ResearchAndMarkets.com's offering.<\/p>\n
The cell and gene therapy market size was valued at USD 4.99 billion in 2021 and is expected to reach USD 36.92 billion by 2027, growing at a CAGR of 39.62 % during the forecast period<\/p>\n
In the cell and gene therapy field, gene therapy gathered the pace last from 2 decades because of the discovery of several genes responsible for mutation in various diseases. The advancement in the cell & gene therapy field and innovative technologies give the new era for biological therapeutics. Also, PRIME Designation and marketing authorization for products provide a new opportunity for the manufacturer's financing and revenue generation.<\/p>\n
KEY HIGHLIGHTS<\/p>\n
As per the American Society of Cell + Gene Therapy report in 2021, increasing the number of cellular and gene therapy products, application rate and products in clinical trials drive the market growth.<\/p>\n
As per the Dive Biopharma report 2021, biotech companies who actively engaged in regenerative medicines and therapies reported USD 14 billion funding only in six months of 2021 which was reported to be USD 19.9 billion for the overall year.<\/p>\n
CELL AND GENE THERAPY MARKET SEGMENTATION<\/p>\n
Increasing application of gene therapies in diseases diagnosis and rapidly growing new drugs applications will give new market space in upcoming years. In 2020, around USD 2.3 billion funding was reported only from private companies for gene therapies. By 2025, the FDA is expected to approve 10?20 products each year, driving the global cell and gene therapy manufacturing market.<\/p>\n
In 2020, Medicine in Development Report 2020, around 176 products were reported in cancer therapies in development procedures.<\/p>\n
GEOGRAPHICAL OUTLOOK<\/p>\n
North America: High economic status and high expenditure on healthcare services drive the cell and gene therapy market in North America. National Health Institutes, industries, academic institutes, and hospitals are the significant contributors of sponsorship and financial funding for cell and gene therapy products.<\/p>\n
Europe: The increasing funding for cell and gene therapy drives the cell and gene therapy market growth consistently in Europe. Around USD 2.6 billion financings were reported in Europe for CGTs in 2020, which increased by 103% compared to previous years. In the cell therapy segment, USD 1.8 billion and in gene therapy, USD 2.3 billion funding accounted in 2020, which increased by 196% and 111% growth respectively<\/p>\n
VENDOR LANDSCAPE<\/p>\n
The key players in the cell and gene therapy market are Gilead Sciences, Novartis, Smith Nephew, Amgen, Organogenesis, Roche (Spark Therapeutics), Dendreon, Vericel, and Bristol-Myers Squibb Company.<\/p>\n
An increasing number of mergers and acquisitions gives new potential to market growth. Gilead Sciences acquired Kite Pharma in 2020. Also, Novartis acquired Avexis in 2018, and Smith & Nephew acquired Osiris Therapeutics.<\/p>\n
MAJOR GROWTH FACTORS<\/p>\n
KEY VENDORS<\/p>\n
OTHER PROMINENT VENDORS<\/p>\n
UPCOMING VENDORS<\/p>\n
Key Topics Covered: <\/p>\n
1 Research Methodology<\/p>\n
2 Research Objectives<\/p>\n
3 Research Process<\/p>\n
4 Scope & Coverage4.1 Market Definition4.2 Base Year4.3 Scope of The Study<\/p>\n
5 Report Assumptions & Caveats5.1 Key Caveats5.2 Currency Conversion5.3 Market Derivation<\/p>\n
6 Market at a Glance<\/p>\n
7 Introduction7.1 Overview7.1.1 Cell & Gene Therapy Approved Products 2020-20217.2 Cell & Gene Therapy Phase-III Products7.3 Road Map of Cell & Gene Therapy<\/p>\n
8 Market Opportunities & Trends8.1 Rising Number of Mergers & Acquisitions8.2 Expansion of CGT Manufacturing Plants8.3 Expanding Applications for Cell & Gene Therapies8.4 Growing Demand for Car T-Cell Therapies<\/p>\n
9 Market Growth Enablers9.1 New Product Approvals & Increasing Pipeline of Products9.2 Prime Designation & Funding Support For CGT9.3 Rising Use of CGT Products for Disease Care9.4 Increasing Use of CGT Products for Disease Treatment<\/p>\n
10 Market Restraints10.1 High Cost of Cell & Gene Therapies10.2 Ethical Issues Regarding Genetical Material10.3 Stringent Regulation for CGT Approvals<\/p>\n
11 Market Landscape11.1 Market Overview11.2 Market Size & Forecast11.3 Five Forces Analysis<\/p>\n
12 Therapy12.1 Market Snapshot & Growth Engine12.2 Market Overview12.3 Gene Therapy12.4 Cell Therapy<\/p>\n
13 Application13.1 Market Snapshot & Growth Engine13.2 Market Overview13.3 Oncology13.4 Genetic Disorders13.5 Dermatology13.6 Musculoskeletal Diseases13.7 Other Diseases<\/p>\n
14 End-User14.1 Market Snapshot & Growth Engine14.2 Market Overview14.3 Hospitals14.4 Cancer Care Centers14.5 Wound Care Centers14.6 Other End-Users<\/p>\n
15 Geography15.1 Market Snapshot & Growth Engine15.2 Geographic Overview15.2.1 Global Cell & Gene Therapy Market by Geography<\/p>\n
For more information about this report visit https:\/\/www.researchandmarkets.com\/r\/z7gm5<\/a><\/p>\n Media Contact:<\/p>\n Research and Markets Laura Wood, Senior Manager [emailprotected] <\/p>\n For E.S.T Office Hours Call +1-917-300-0470 For U.S.\/CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 <\/p>\n U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716<\/p>\n SOURCE Research and Markets<\/p>\n <\/p>\n Here is the original post: DUBLIN, Feb. 1, 2022 \/PRNewswire\/ -- The \"Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027\" report has been added to ResearchAndMarkets.com's offering. Continue reading
\nGlobal Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"